[Expression of cell cycle control genes in myelodysplastic syndromes]
- PMID: 15946501
[Expression of cell cycle control genes in myelodysplastic syndromes]
Abstract
Objective: To study aberrant expression of cell cycle control genes in patients with myelodysplastic syndromes (MDS).
Methods: Reverse transcription polymerase chain reaction (RT-PCR) was used to investigate the expression of cell cycle control genes (cyclin D2, cyclin D3, cyclin A1, cyclin E, CDK2, CDK4, CDK6, p21, p27, p57, Rb and E2F1) in bone marrow mononuclear cells (BMMNCs) from 29 normal control, 27 MDS and 19 de novo acute myeloid leukemia (AML).
Results: The expression levels of cyclin D3 (0.65 +/- 0.17, P < 0.05) and cyclin A1 (0.48 +/- 0.04, P < 0.05) in MDS were higher than those in normal control and significantly lower than those in AML. The expression rates and levels of cyclin D2 (40.7% and 0.78 +/- 0.21) and cyclin E (51.9% and 0.52 +/- 0.10) in MDS were statistically higher than those in normal control and AML. The expression level of CDK2 in MDS (0.66 +/- 0.19, P < 0.01) was higher than that in normal control (0.42 +/- 0.04) and the expression rate of CDK6 in MDS (25.9%) higher than in normal control (3.4%, P < 0.05). There was no significant difference of the expression rates and levels of CDK4 in MDS, AML and normal control. The expression rates and levels of p21 (77.8% and 1.18 +/- 0.21) and p27 (48.1% and 1.14 +/- 0.40) in MDS were statistically higher than those in normal control and AML. The expression level of p57 in MDS (0.69 +/- 0.06) was higher than that (0.53 +/- 0.05, P < 0.01) in normal control but lower than in AML (0.96 +/- 0.16, P < 0.01). The expression rate (55.6%) and level (0.85 +/- 0.17) of Rb in MDS were significantly higher than those in normal control and AML. The expression rate (7.4%) and level (0.39 +/- 0.04) of E2F1 in MDS were comparable to those in normal control but lower than those in AML.
Conclusion: MDS clones have aberrant mechanism of cell cycle control: high expressions of cyclin family members, CDK2 and CDK6 may lead to high proliferation; high expression of p21 and p27 may cause the G1 phase arrest.
Similar articles
-
[Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].Zhonghua Xue Ye Xue Za Zhi. 2004 Nov;25(11):641-4. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15634564 Chinese.
-
Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).J Pathol. 2008 Jul;215(3):253-62. doi: 10.1002/path.2352. J Pathol. 2008. PMID: 18438954
-
Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.Leuk Res. 2006 Nov;30(11):1347-53. doi: 10.1016/j.leukres.2006.03.015. Epub 2006 May 8. Leuk Res. 2006. PMID: 16682076
-
Nuclear PI-PLC β1 and Myelodysplastic syndromes: from bench to clinics.Curr Top Microbiol Immunol. 2012;362:235-45. doi: 10.1007/978-94-007-5025-8_11. Curr Top Microbiol Immunol. 2012. PMID: 23086421 Review.
-
Nuclear Inositide Signaling Via Phospholipase C.J Cell Biochem. 2017 Aug;118(8):1969-1978. doi: 10.1002/jcb.25894. Epub 2017 Apr 25. J Cell Biochem. 2017. PMID: 28106288 Review.
Cited by
-
Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.Korean J Intern Med. 2019 Mar;34(2):390-400. doi: 10.3904/kjim.2016.239. Epub 2017 Nov 15. Korean J Intern Med. 2019. PMID: 29132200 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous